-
-
-
-
-
-
-
VIVUS (VVUS) In the Spotlight Ahead of Likely FDA Obesity Drug Approval
-
-
-
-
-
-
-
Notable Analyst Rating Changes 03/12: (OREX) (CCL) (LOW) Upgraded; (ORCL) (LUV) (HEK) Downgraded
-
-
-
-
-
-
-
Orexigen (OREX) volatility elevated at 143
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 1/9: PALM, HWAY, RAMS, AMMD Higher; RGN, WSCI, RMBS, OREX Lower
72,201 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

